SS
PHIO icon

SBI Securities’s Phio Pharmaceuticals PHIO Stock Holding History

SBI Securities’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49K Buy
1,224
+89
+8% +$102 ﹤0.01% 2508
2025
Q4 		$1.19K Buy
1,135
+34
+3% +$54 ﹤0.01% 2579
2025
Q3 		$2.73K Sell
1,101
-808
-42% -$1.84K ﹤0.01% 2305
2025
Q2 		$4.49K Buy
1,909
+941
+97% +$1.9K ﹤0.01% 2034
2025
Q1 		$1.26K Buy
968
+905
+1,437% +$1.67K ﹤0.01% 2487
2024
Q4 		$113 Buy
+63
New +$171 ﹤0.01% 3423

Other funds holding PHIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SBI Securities's PHIO Position: Q1 2026 in Review

SBI Securities increased its Phio Pharmaceuticals (PHIO) stake by 7.8% in Q1 2026, buying an estimated $102 and bringing the position to 1,224 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #2508.

SBI Securities first reported a position in PHIO in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.49K in Q2 2025. 24 funds tracked by Wall St. Rank hold PHIO as of Q1 2026.

  • SBI Securities held 1,224 shares of Phio Pharmaceuticals worth $1.49K as of Q1 2026.
  • SBI Securities bought 89 Phio Pharmaceuticals shares in Q1 2026, an estimated $102.
  • Phio Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2508 holding.
  • SBI Securities first reported a position in Phio Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Phio Pharmaceuticals position peaked at $4.49K in Q2 2025.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.